• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Stroke survivors face high risk of visual problems
Up to six in 10 stroke survivors experience new visual problems prompted by their stroke Related items fromOnMedica Loneliness itself appears not to raise risk of heart attack/stroke NICE wants GPs to prevent 8,000 strokes a year Regular GP pulse checks of elderly patients could prevent strokes, study finds Experts warn of heart risks for people with diabetes Wait and hip measurement better indicator of heart attack risk than obesity
Source: OnMedica Latest News - March 11, 2019 Category: UK Health Source Type: news

The World & #039;s Most Innovative Medtech Companies
Innovation is medtech's middle name, so it's always a nice surprise to see companies in the industry honored for being innovative. Fast Company released a list Wednesday recognizing 10 such companies in the biotech sector. Below, we highlight the companies on the list that are developing medical devices or diagnostics (excluding companies that are more on the pharma and biotech side of the life sciences industry). Foundation Medicine Foundation Medicine develops genomic profiling assays to pair cancer patients with relevant treatments and clinical trials. The company was ranked first among the Top 1...
Source: MDDI - February 20, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Reply: Septic cerebral emboli as a risk factor for thrombolysis-related haemorrhagic transformation
We appreciate the opportunity to respond to Dr. Jolobe ’s letter titled ‘Septic cerebral emboli as a risk factor for thrombolysis-related hemorrhagic transformation’. Dr. Jolobe made a nice comment on our article titled ‘Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction’.1 We agree that septic cerebral emboli was a risk factor for thrombolysis-related hemorrhagic transformation as demonstrated in an early study.2 In fact, it was based on this early study and the following studies that intravenous thrombolysis is not recommended for patients with acut...
Source: QJM - January 25, 2019 Category: Internal Medicine Source Type: research

Thrombectomy to be offered up to 24h after onset of stroke
NICE recommends procedure in new draft guideline Related items fromOnMedica Stroke survivors need more help taking medicine Stroke deaths falling in Europe, overall Diagnosing a transient ischaemic attack One in two women and one in three men will develop neurological disease Having a stroke doubles dementia risk
Source: OnMedica Latest News - November 26, 2018 Category: UK Health Source Type: news

Thrombectomy can be considered up to 24 hours after onset of stroke, says NICE
Source: BMJ News - November 23, 2018 Category: General Medicine Source Type: research

Grouping existing medications slows antibiotic resistance
Scientists identify new antibiotic combinations Related items fromOnMedica Doctors face legal action over use of unlicensed eye drug Put case for adding leukaemia drug to Cancer Drugs Fund, NICE tells company Increased antidepressants prescribing shouldn't 'automatically be seen as a bad thing', says RCGP Not so ‘smart’ drugs Stroke survivors need more help taking medicine
Source: OnMedica Latest News - September 5, 2018 Category: UK Health Source Type: news

NICE calls for consistent clinical and social care in cerebral palsy
Primary care services must address barriers to adults with cerebral palsy accessing care Related items fromOnMedica Emergency admissions at end of life set to sky rocket ‘Friends& family test ’ should not be mandatory Diagnosis targets unethical says GP CQC tells Trust to improve safety of 111 service Stroke survivors need more help taking medicine
Source: OnMedica Latest News - July 16, 2018 Category: UK Health Source Type: news

Basilar artery occlusion with “seizures” as a presenting symptom: three cases treated using mechanical thrombectomy
We present 3 cases of patients with BAO presenting with seizures.
Source: World Neurosurgery - June 7, 2018 Category: Neurosurgery Authors: Ryosuke Otsuji, Junji Uno, Ryota Motoie, Satoshi Karashima, Nice Ren, Shintaro Nagaoka, Maeda Kazushi, Yoshiaki Ikai, Hidefuku Gi Tags: Case Report Source Type: research

108appropriate anticoagulation in older adults with atrial fibrillation
Introduction: Anticoagulation is recommended to prevent stroke in atrial fibrillation. NICE Guidelines state anticoagulation should be offered to all patients with a CHADVASC of 2 and above. The ESC (European Society of Cardiology) guidelines advise falls and advanced dementia should not prevent patients from receiving anticoagulation. Furthermore, advanced age (above 75 or 80 years old) should not mean anticoagulation is withheld, especially as the risk of ischaemic stroke increases with age and comorbidities.
Source: Age and Ageing - March 27, 2018 Category: Geriatrics Source Type: research

89implementing evidence based practice: an audit of intermittent pneumatic compression (ipc) prescription in stroke at a district stroke centre
Introduction: The CLOTS III randomised control trail demonstrated that “IPC is an effective and inexpensive method of reducing the risk of DVT and improving survival in immobile stroke patients.”1. DVT risk is highest amongst stroke patients following immobilisation and NICE (CG 92) recommends application of IPC devices and documentation of a decision for or against them in this high risk patient group.
Source: Age and Ageing - March 27, 2018 Category: Geriatrics Source Type: research

Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
AbstractThe National Institute for Health and Care Excellence (NICE) invited AstraZeneca, the manufacturer of ticagrelor (Brilique®), to submit evidence on the clinical and cost effectiveness of ticagrelor 60  mg twice daily (BID) in combination with low-dose aspirin [acetylsalicylic acid (ASA)] compared with ASA only for secondary prevention of atherothrombotic events in patients with a history of myocardial infarction (MI) and who are at increased risk of atherothrombotic events. Kleijnen Systematic R eviews Ltd (KSR), in collaboration with Maastricht University Medical Centre+, was commissioned as the evidence review ...
Source: PharmacoEconomics - January 18, 2018 Category: Health Management Source Type: research

Neurosurgical Intensive Care
Neurocritical care as a subspecialty has grown rapidly over the last two decades, including fast-growing new techniques in neuromonitoring, neuroimaging, and various therapeutic tools.Neurosurgical Intensive Care by Javed Siddiqi is a focused, concise handbook that provides a quick review mainly for residents and fellows receiving training in neurocritical care, but also provides a useful refresher for other healthcare professionals providing care to critically ill neurosurgical patients. The book has 31 chapters with some changes in the table of contents and the addition of two chapters compared with the first edition. Ne...
Source: Anesthesiology - January 17, 2018 Category: Anesthesiology Source Type: research

103 How is our local AF management? The management of atrial fibrillation (af) in coventry and rugby clinical commissioning group (ccg), england compared to national data and nice (national institute for clinical excellence) 2014
Background: AF is the most common cardiac arrhythmia affecting 2% in the UK.AF carriers 5 fold risk of stroke, with increased stroke mortality, morbidity& longer hospital stay.CHADSVAs guides anti-coagulation ( ≥1 anti-coagulate)Risk factor modification reduces AF reoccurrenceNurse led clinics reduce AF related stroke risk, improve AF management, risk factor reduction whilst providing safe anticoagulation.
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

115 Anticoagulation in atrial fibrillation – a single-centre audit on patient education, stroke and bleeding risk assessments and use of direct oral anticoagulants (DOACs)
Objective: To assess adherence to the National Institute of Health and Care Excellence (NICE) guidelines on management of atrial fibrillation in adults, specifically the provision of a personalised package of care and information to patients, and stroke and bleeding risk assessments. To assess the frequency of use of DOACs as the anticoagulant of choice.
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

124 GP-led anticoagulation counselling for non-valvular atrial fibrillation (AF) in the community is neither comprehensive nor accurate: Results from a service improvement project.
Background: Stroke risk in NVAF can be reduced significantly by anticoagulation with either warfarin or the non- vitamin K antagonist (NOACs). NICE recommendations state that NOACs are as efficacious but also associated with significantly less intracranial bleeding compared to Warfarin and in this sense are safer than warfarin. Additionally NOACs do not require regular monitoring of their anticoagulant effects and therefore offer convenience to the patient. However they are not as tried and tested as warfarin and at the time of our study, did not have an available agent to reverse their effects in the event of a bleeding c...
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11